Show simple item record

dc.contributor.authorMeredith, T. Jen
dc.contributor.authorJacobsen, Den
dc.contributor.authorHaines, J. Aen
dc.contributor.authorBerger, J.-Cen
dc.contributor.authorWorld Health Organizationen
dc.contributor.authorCommission of the European Communitiesen
dc.contributor.authorInternational Labour Organizationen
dc.date.accessioned2012-06-16T14:02:18Z
dc.date.available2012-06-16T14:02:18Z
dc.date.created1993en
dc.date.issued1993en
dc.identifier.urihttps://iris.who.int/handle/10665/39114
dc.descriptionPublished by Cambridge University Press in behalf of the World Health Organization and the Commission of the European Communitiesen
dc.description98 p.en
dc.language.isoenen
dc.publisherCambridge : Cambridge University Pressen
dc.relation.ispartofseriesIPCS/CEC evaluation of antidotes series ; v. 1en
dc.subject.meshNaloxoneen
dc.subject.meshFlumazenilen
dc.subject.meshDantroleneen
dc.subject.meshAntidotesen
dc.subject.otherChemical Toxicology and Carcinogenicityen
dc.titleNaloxone, flumazenil and dantrolene as antidotes / scientific editors, T. J. Meredith ... [‎et al.]‎en


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(‎s)‎

Show simple item record